キュレーション · ヘルスケア

Big pharma

InspectStocks 編集Published 2026年10月14日13 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

AI モデルの助けを借りてグループ分けし、編集部が確認しました。各企業の下の一行が、ここに入っている理由を説明します。

Download image

カードティア

株価は2026年11月11日の終値です（IEX取引所のデータ）。

Grade mix

A 7B 3C 3

Revenue growing

12 of 12

Free cash flow growing

9 of 13

Median price move, 1 year

+34.0%

Sort by

LLYELI LILLY AND COMPANY
Drug manufacturers generalMarket cap $1.35TP/E 46.67
$1,437.79+42.2%1Y
Since added +23.2%
A+
成長と現金
力強く成長
Business trend
安定
Business quality
高い
Getting better
改善中
Revenue
$86.5B+45.5%
Profit
$27.6B+49.8%
Free cash flow
$19.7B+112.1%
Discuss
Why it is here: Sells prescription medicines for diabetes, obesity, cancer and inflammation
JNJJohnson & Johnson
Drug manufacturers generalMarket cap $674.9BP/E 42.54
$280.34+47.5%1Y
Since added +12.8%
A+
成長と現金
力強く成長
Business trend
安定
Business quality
高い
Getting better
まちまち
Revenue
$99.3B+7.8%
Profit
$16.1B-35.9%
Free cash flow
$20.6B+5.1%
Discuss
Why it is here: Sells prescription medicines for cancer and immune disorders
ABBVAbbVie Inc.
Drug manufacturers generalMarket cap $521.2BP/E 50.75
$294.87+30.2%1Y
Since added +7.5%
B+
成長と現金
力強く成長
Business trend
安定
Business quality
高い
Getting better
改善中
Revenue
$66B+10.7%
Profit
$10.3B+333.1%
Free cash flow
$18.9B-4.1%
Discuss
Why it is here: Sells medicines for immune, neurological and cancer conditions
MRKMerck & Co., Inc.
Drug manufacturers generalMarket cap $362.9BP/E 150.20
$147.20+65.7%1Y
Since added +3.7%
A
成長と現金
力強く成長
Business trend
安定
Business quality
堅実
Getting better
まちまち
Revenue
$67.4B+4.9%
Profit
$2.5B-87.1%
Free cash flow
$14.7B+13.0%
Discuss
Why it is here: Sells prescription medicines and vaccines for people and animals
NVSNovartis AG
Drug manufacturers generalMarket cap $306BPERなし（営業損失）
$160.36+23.6%1Y
Since added +12.6%
A
成長と現金
力強く成長
Business quality
まちまち
Getting better
大きく改善
Revenue
$56.7B+9.6%
Profit
-$46MNo comparable year
Free cash flow
$17.6B+8.3%
Discuss
Why it is here: Sells prescription medicines
AZNASTRAZENECA PLC
Drug manufacturers generalMarket cap $289.7BP/E 28.36
$185.49+115.2%1Y
Since added +19.0%
B+
成長と現金
力強く成長
Business trend
減速
Business quality
高い
Getting better
大きく改善
Revenue
$62.4B+7.3%
Profit
$10.2B+45.3%
Free cash flow
$11.8B+18.4%
Discuss
Why it is here: Sells prescription medicines
NVONOVO NORDISK A/S
Drug manufacturers generalMarket cap $182.8BP/E 11.84
$41.10-15.4%1Y
Since added +8.0%
C+
成長と現金
成長中
Business trend
加速
Business quality
高い
Getting better
改善中
Revenue
$50.3B+5.7%
Profit
$17.1B+9.1%
Free cash flow
$8.9B-20.1%
Discuss
Why it is here: Sells diabetes and obesity medicines
PFEPFIZER INC
Drug manufacturers generalMarket cap $167.9BP/E 42.07
$29.45+21.4%1Y
Since added +3.8%
C
成長と現金
力強く成長
Business trend
縮小
Business quality
堅実
Getting better
まちまち
Revenue
$63.6B+1.3%
Profit
$4B-59.0%
Free cash flow
$11.8B+13.6%
Discuss
Why it is here: Sells prescription medicines and vaccines
BMYBRISTOL-MYERS SQUIBB COMPANY
Drug manufacturers generalMarket cap $128.6BP/E 13.95
$62.92+34.0%1Y
Since added +11.0%
C+
成長と現金
成長中
Business trend
安定
Business quality
高い
Getting better
大きく改善
Revenue
$50B+4.2%
Profit
$9.2B+53.1%
Free cash flow
$9.3B-39.3%
Discuss
Why it is here: Sells prescription medicines for cancer and immune conditions
SNYSanofi
Drug manufacturers generalMarket cap $59.1BP/E 6.81
$48.43-3.0%1Y
Since added +23.9%
B
成長と現金
力強く成長
Business trend
安定
Business quality
まちまち
Getting better
改善中
Revenue
$53.5B+11.6%
Profit
$4.7B-54.2%
Free cash flow
$8.1B+22.5%
Discuss
Why it is here: Sells prescription medicines and vaccines
GSKGSK plc
Drug manufacturers generalMarket cap $109.2BP/E 13.60
$50.60+8.9%1Y
Since added +9.3%
A+
成長と現金
力強く成長
Business quality
高い
Getting better
大きく改善
Revenue
$43.8B+4.1%
Profit
$7.7B+122.0%
Free cash flow
$8.6B+24.0%
Discuss
Why it is here: Sells prescription medicines and vaccines worldwide
AMGNAmgen Inc.
Drug manufacturers generalMarket cap $253.2BP/E 27.14
$468.13+43.1%1Y
Since added +13.4%
A+
成長と現金
力強く成長
Business trend
安定
Business quality
高い
Getting better
改善中
Revenue
$38.9B+8.2%
Profit
$9.4B+34.1%
Free cash flow
$9.6B-17.0%
Discuss
Why it is here: Develops and sells medicines and biosimilars for serious diseases
TAKTakeda Pharmaceutical Company Limited
Drug manufacturers specialty and genericMarket cap $33.5BP/E 48.79
$20.86+50.1%1Y
Since added +12.5%
A
成長と現金
力強く成長
Business quality
まちまち
Getting better
まちまち
Revenue
$29.8BNo comparable year
Profit
$259.4MNo comparable year
Free cash flow
$5.5B+1.1%
Discuss
Why it is here: Sells prescription medicines and vaccines globally

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Be civil and stick to the companies. Comments are opinions, not advice.

Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.